Results 101 to 110 of about 1,734 (194)

Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation

Viruses
This systematic review discusses the use of prophylaxis to prevent cytomegalovirus (CMV) infection in recipients who have undergone hematopoietic cell transplantation. It highlights the need for new approaches to control and prevent CMV infection.
Tang-Her Jaing, Yi-Lun Wang, Chia-Chi Chiu   +2 more
doaj   +1 more source

Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation [PDF]

, 2020
INTRODUCTION Cytomegalovirus (CMV) infection following allogeneic hematopoietic stem cell transplantation (HSCT) is a major cause of morbidity and mortality.
Mehra, V, Peggs, KS, Roddie, C, Shafat, MS   +3 more
core  

HIV and cytomegalovirus in Thailand. [PDF]

, 2005
Arlene Chua, Ausayakhun, David Wilson, Ford, Gandhi, Nathan Ford, Wilson   +6 more
core   +1 more source

Pharmacokinetic Drug Interaction Studies with Enzalutamide [PDF]

, 2015
Jacqueline A. Gibbons, Jan Noukens, Jan-Stefan van der Walt, Joyce Mordenti, Michiel de Vries, Roelof Mol, Taoufik Ouatas, Walter Krauwinkel, Yoshiaki Ohtsu   +8 more
core   +1 more source

Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update [PDF]

Cytomegalovirus (CMV) infection remains a significant challenge in solid organ transplantation (SOT). The last international consensus guidelines on the management of CMV in SOT were published in 2018, highlighting the need for revision to incorporate ...
Aguilera, Victoria, Alonso, Rodrigo, Berenguer, Marina, Bestard, Oriol, Bodro, Marta, Cantisán, Sara, Carratalà, Jordi, Catón, Juan José, Cordero, Elisa, Facundo, Carme, Fariñas Álvarez, María del Carmen, Fernández-Alonso, Mirian, Fernández-Ruiz, Mario, Fortún, Jesús, García-Cosío, María Dolores, Herrera, Sabina, Iturbe Fernández, David, Len, Óscar, Ruiz-Arabi, Elisa, Torre-Cisneros, Julián   +19 more
core   +1 more source

Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review

Pharmaceutics
Cytomegalovirus (CMV) poses a significant threat to post-hematopoietic cell transplantation (HCT). Control strategies include letermovir prophylaxis or ganciclovir pre-emptive therapy (PET).
Tayná F. G. S. Bandeira, Luciana C. Marti, Edna T. Rother, Lucas Reis Correia, Clarisse M. Machado   +4 more
doaj   +1 more source

The role of Luteolin, Midostaurin( PKC-412) and PD173074 in Human Cytomegalovirus (HCMV) life cycle [PDF]

, 2016
The cytoplasmic assembly compartment (AC) in HCMV-infected human foreskin fibroblasts (HFF) is a unique juxtanuclear ―bulb‖-like structure. Morphology of the AC is dependent on the activity of the viral-encoded serine/threonine kinase, pUL97.
Amer Izzat Mohammad Doufish, عامر عزت محمد دوفش   +1 more
core  

Issue Information

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 8, Page 1285-1288, August 2025.
wiley   +1 more source

Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review

Tropical Medicine and Infectious Disease
Human cytomegalovirus (HCMV) is a pathogen with high prevalence in the general population that is responsible for high morbidity and mortality in immunocompromised individuals and newborns, while remaining mainly asymptomatic in healthy individuals.
Ivana Grgic, Lana Gorenec
doaj   +1 more source

CMV-RNAemia as new marker of active viral replication in transplant recipients [PDF]

N
Bonifazi F., Borgatti E. C., Cantiani A., Franceschiello M., Gabrielli L., Giannella M., Gibertoni D., Lanna F., Lazzarotto T., Leone M., Motta V., Pascale R., Pavoni M., Piccirilli G.   +13 more
core   +1 more source